Publication | Open Access
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma
74
Citations
52
References
2016
Year
Patients with primary GBMs with low MMP9 expression may have longer survival and may benefit from temozolomide chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1